PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-53.88%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
118.21%
Positive EBIT growth while XRF.AX is negative. John Neff might see a substantial edge in operational management.
118.21%
Positive operating income growth while XRF.AX is negative. John Neff might view this as a competitive edge in operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.49%
Share count expansion well above XRF.AX's 1.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
60.93%
Diluted share count expanding well above XRF.AX's 1.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
130.13%
Positive OCF growth while XRF.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-46.67%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
188.14%
10Y revenue/share CAGR 1.25-1.5x XRF.AX's 151.40%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
4125.22%
5Y revenue/share CAGR above 1.5x XRF.AX's 74.52%. David Dodd would look for consistent product or market expansions fueling outperformance.
No Data
No Data available this quarter, please select a different quarter.
129.75%
10Y OCF/share CAGR in line with XRF.AX's 132.15%. Walter Schloss would see both as similarly efficient over the decade.
148.45%
Below 50% of XRF.AX's 1139.05%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
No Data
No Data available this quarter, please select a different quarter.
-5.76%
Negative 10Y net income/share CAGR while XRF.AX is at 198.79%. Joel Greenblatt sees a major red flag in long-term profit erosion.
No Data
No Data available this quarter, please select a different quarter.
141.41%
3Y net income/share CAGR above 1.5x XRF.AX's 72.97%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
382.46%
R&D growth of 382.46% while XRF.AX is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
89.07%
We expand SG&A while XRF.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.